Montelukast Prescribing at QUINCY RISE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
143
Total Quantity
9,566
NHS Cost
£436
vs National Avg
-79.1%
QUINCY RISE SURGERY prescribed 143 items of Montelukast over the last 12 months at a cost of £436 to the NHS. This is 79.1% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
17
Jul 2026
8
Jul 2026
15
Jul 2026
11
Jul 2026
11
Jul 2026
9
Jul 2026
17
Jul 2026
8
Jul 2026
9
Jul 2026
14
Jul 2026
12
Jul 2026
12
Prescribing Details
| Total Items | 143 |
|---|---|
| Total Quantity | 9,566 |
| Total NHS Cost | £436 |
| Presentations | 2 different forms |
| vs National Average | -79.1% |
Montelukast Prescribing Comparison
| This practice | 143 items |
|---|---|
| National average per practice | 685 items |
| Difference | -79.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.